This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a piperazine ring, makes it valuable in the development of drugs targeting neurological and psychiatric disorders. It is often incorporated into molecules designed to interact with neurotransmitter receptors, particularly in the creation of antipsychotic and antidepressant medications. Additionally, its nitrile group can be further modified to introduce other functional groups, enhancing its versatility in drug design. The compound’s stability and reactivity also make it suitable for use in organic synthesis and research applications, particularly in the exploration of new therapeutic agents.